Hodgkins Lymphoma: Clinical Trials

6 trials for Hodgkins Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 1 active not recruiting. 6 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Completed 3, Terminated 2, Active not recruiting 1
Phase 11Active not recruiting 1

Follow Hodgkins Lymphoma: new trials by email Literature Review of Hodgkins Lymphoma trials Research Report on Hodgkins Lymphoma

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Ossium HPC Marrow, Bone Marrow Transplant, Pre-transplant conditioning - Myeloablative (MAC), Pre-transplant conditioning - Reduced Intensity (RIC) - Acute Leukemia, Acute Lymphoblastic Leukemia
Phase 1 / Phase 2Active not recruitingOssium Health, Inc.122024-08-162026-09-10
Allogeneic Stem Cell Transplantation With Adoptive Immunotherapy in Epstein-Barr Virus Positive Recurrent/Refractory Hodgkins Lymphoma
allogeneic donor derived LMP specific cytotoxic T-lymphocyte - Hodgkins Lymphoma
Phase 2TerminatedNew York Medical College22013-01-012017-12-22
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
Fludarabine monophosphate, Busulfan, Stem Cell Infusion - Leukemia, Acute Myeloid Leukemia
Phase 2CompletedM.D. Anderson Cancer Center2012012-04-112023-06-29
Oncaspar/Doxil/Decadron in Patients With Refractory Lymphoid Malignancies
Oncaspar, Doxil, Decadron - Non-hodgkins Lymphoma, Hodgkins Lymphoma
Phase 2TerminatedMilton S. Hershey Medical Center132009-03-012017-07-24
Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
fludarabine, cyclophosphamide, thiotepa, radiation therapy, unrelated donor umbilical cord blood graft - Leukemia, Myelodysplastic Syndrome
Phase 2CompletedMemorial Sloan Kettering Cancer Center862008-08-122022-12-08
Protection of Ovarian Function in Female Patients With Hodgkin Lymphoma
8 cycles BEACOPPesc plus oral contraceptive, 8 cycles BEACOPPesc plus Goserelin - Hodgkins Lymphoma
Phase 2CompletedUniversity of Cologne602004-01-012012-06-25

Narrower conditions

Hodgkin Disease (6)  ·  Leukemia (3)  ·  Leukemia, Myelogenous, Chronic, BCR-ABL Positive (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Leukemia, Myeloid, Acute (2)  ·  Lymphoma (2)  ·  Multiple Myeloma (2)  ·  Myelodysplastic Syndromes (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Hematologic Diseases (1)  ·  Leukemia, B-Cell (1)  ·  Leukemia, Biphenotypic, Acute (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, T-Cell, Cutaneous (1)

Broader conditions

Hemic and Lymphatic Diseases (6)  ·  Immune System Diseases (6)  ·  Immunoproliferative Disorders (6)  ·  Lymphatic Diseases (6)  ·  Lymphoproliferative Disorders (6)  ·  Neoplasms (6)  ·  Neoplasms by Histologic Type (6)  ·  Lymphoma (4)  ·  Bone Marrow Diseases (3)  ·  Chronic Disease (3)  ·  Disease Attributes (3)  ·  Hematologic Diseases (3)  ·  Leukemia, Myeloid (3)  ·  Myeloproliferative Disorders (3)  ·  Pathologic Processes (3)

Interventions

Cyclophosphamide (2)  ·  Filgrastim (2)  ·  fludarabine phosphate (2)  ·  Bone Marrow Transplantation (1)  ·  Busulfan (1)  ·  Calcium Dobesilate (1)  ·  Contraceptives, Oral (1)  ·  Goserelin (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Melphalan (1)  ·  Mesna (1)  ·  Methotrexate (1)  ·  Mycophenolic Acid (1)  ·  Radiotherapy (1)  ·  Tacrolimus (1)

Sponsors

M.D. Anderson Cancer Center (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Milton S. Hershey Medical Center (1)  ·  New York Medical College (1)  ·  Ossium Health, Inc. (1)  ·  University of Cologne (1)

Countries

United States (5)

Top investigators

Joseph J. Drabick, MD (1)  ·  Juliet Barker, MBBS (1)  ·  Mitchell S Cairo, MD (1)  ·  Uday Popat, MD (1)

Results publications

PMID 20305034, PMID 23416850, PMID 30389035